Evidence map›Paper›PMID 36614027›Full record

ArticleInternational journal of molecular sciences2022

Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis.

Hans K Ghayee, Yiling Xu, Heather Hatch, Richard Brockway, Asha S Multani, Tongjun Gu, Wendy B Bollag, Adina Turcu, William E Rainey, Juilee Rege and 8 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Hans K GhayeeDivision of Endocrinology & Metabolism, University of Florida, Gainesville, FL 32610, USA.
Yiling XuDivision of Endocrinology & Metabolism, University of Florida, Gainesville, FL 32610, USA.
Heather HatchDepartment of Physiological Sciences, University of Florida, Gainesville, FL 32603, USA.ORCID 0000-0003-3447-4688
Richard BrockwayDepartment of Physiological Sciences, University of Florida, Gainesville, FL 32603, USA.
Asha S MultaniDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Tongjun GuDepartment of Bioinformatics, University of Florida, Gainesville, FL 32610, USA.
Wendy B BollagCharlie Norwood VA Medical Center, Augusta, GA 30904, USA.ORCID 0000-0003-3146-162X
Adina TurcuDivision of Endocrinology & Metabolism, University of Michigan, Ann Arbor, MI 48109-5624, USA.
William E RaineyDivision of Endocrinology & Metabolism, University of Michigan, Ann Arbor, MI 48109-5624, USA.
Juilee RegeDivision of Endocrinology & Metabolism, University of Michigan, Ann Arbor, MI 48109-5624, USA.
Kazutaka NanbaDivision of Endocrinology & Metabolism, University of Michigan, Ann Arbor, MI 48109-5624, USA.
Vikash J BhagwandinOncoStemyx, Inc., Palo Alto, CA 94401, USA.
Fiemu NwariakuDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Victor StastnyHamon Center for Therapeutic Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8593, USA.
Adi F GazdarHamon Center for Therapeutic Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8593, USA.
Jerry W ShayDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9039, USA.ORCID 0000-0001-5052-0627
Richard J AuchusDivision of Endocrinology & Metabolism, University of Michigan, Ann Arbor, MI 48109-5624, USA.ORCID 0000-0001-6815-6181
Sergei G TevosianDepartment of Physiological Sciences, University of Florida, Gainesville, FL 32603, USA.
University of Florida · USUniversity of Michigan · USThe University of Texas Southwestern Medical Center · USAugusta University · USThe University of Texas MD Anderson Cancer Center · US

Funding

This research was supported by the Gatorade Trust Fund from the Department of Medicine, University of Florida Gatorade (Project# 00122235), Southeast Center for Integrated Metabolomics, University of Florida, and Malcom Randall VA Pilot Award Program (H.K Project# 00122235
6 · The paper itself

Abstract

The human adrenal cortex is composed of distinct zones that are the main source of steroid hormone production. The mechanism of adrenocortical cell differentiation into several functionally organized populations with distinctive identities remains poorly understood. Human adrenal disease has been difficult to study, in part due to the absence of cultured cell lines that faithfully represent adrenal cell precursors in the early stages of transformation. Here, Human Adrenocortical Adenoma (HAA1) cell line derived from a patient's macronodular adrenocortical hyperplasia and was treated with histone deacetylase inhibitors (HDACis) and gene expression was examined. We describe a patient-derived HAA1 cell line derived from the zona reticularis, the innermost zone of the adrenal cortex. The HAA1 cell line is unique in its ability to exit a latent state and respond with steroidogenic gene expression upon treatment with histone deacetylase inhibitors. The gene expression pattern of differentiated HAA1 cells partially recreates the roster of genes in the adrenal layer that they have been derived from. Gene ontology analysis of whole genome RNA-seq corroborated increased expression of steroidogenic genes upon HDAC inhibition. Surprisingly, HDACi treatment induced broad activation of the Tumor Necrosis Factor (TNF) alpha pathway. This novel cell line we developed will hopefully be instrumental in understanding the molecular and biochemical mechanisms controlling adrenocortical differentiation and steroidogenesis.

Indexed as

Adrenal CortexAdrenocortical AdenomaAdrenal Cortex HormonesCell LineHistone Deacetylase InhibitorsHumansZona ReticularisAdrenal Cortex HormonesHistone Deacetylase Inhibitorsadrenocortical carcinomacell differentiationgene expressionhistone deacetylase inhibitor

Identifiers

PMID36614027
PMCPMC9820690
OpenAlexW4313409535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.